1244 studies found for:    FDG
Show Display Options
Rank Status Study
1 Recruiting Study Evaluating the Utility of 18F-FDG PET in Assessing Early Response to Neoadjuvant Chemotherapy in Patients With Mammary Gland Cancer
Condition: FDG PET
Intervention: Device: FDG PET
2 Not yet recruiting Combined FDG-PET and 123I-Iodometomidate Imaging for Adrenal Neoplasia
Condition: Adrenal Gland Neoplasms
Interventions: Other: FDG positron emission tomography;   Other: Iodometomidate imaging
3 Unknown  18F-FDG PET/CT for IgG4-Related Disease
Condition: Autoimmune Disease
Intervention: Drug: 18F-FDG
4 Completed Creation of a Normal Database for FluoroDeoxyGlucose-Positron Emission Tomography (FDG-PET) Neurological Examinations
Condition: Lymphoma
Intervention: Device: FDG-PET
5 Enrolling by invitation Comparative Study With Different Tracers (18F-FDG and 68Gallium Citrate) in the Diagnosis of Periprosthetic Joint Infection
Condition: Infection and Inflammatory Reaction Due to Internal Joint Prosthesis
Intervention: Other: 68Ga-citrate and 18F-FDG PET scans
6 Recruiting Dual Time Point FDG PET-MR Imaging Optimization for the Evaluation of Glioblastoma
Conditions: Malignant Neoplasms, Eye;   Glioblastoma;   Malignant Neoplasms, Brain;   Malignant Neoplasms, Central Nervous System
Interventions: Drug: FDG;   Procedure: PET/CT;   Procedure: MRI
7 Recruiting A Pilot Study Treatment of Malignant Tumors Using [18F] Fluorodeoxyglucose (FDG)
Conditions: Radiosensitive Stage IV Solid and Hematological Tumors With High FDG Uptake Not Responding to Standard of Care;   Lung Cancer, Head and Neck Cancer, Breast Cancer, Gastric Cancer, Pancreatic Cancer, Colon Cancer, Lymphomas, Sarcomas, Etc
Intervention: Radiation: FDG
8 Active, not recruiting 11C-acetate/18Fluorodeoxyglucose-FDG PET/CT and Cardiac MRI in Pulmonary Hypertension
Condition: Pulmonary Hypertension
Interventions: Drug: 11C-acetate;   Drug: [18F]Fluoro-2-deoxy-2-D-glucose;   Other: Cardiac MRI
9 Active, not recruiting 18F-deoxyglucose (FDG) PET-CMD
Condition: Patients With Idiopathic Dilated Cardiomyopathy
Intervention: Drug: 18F-deoxyglucose (FDG)
10 Recruiting MRI FDG PET Imaging Cervix
Condition: Cervical Cancer Squamous Cell
Intervention: Biological: 18-FDG PET/CT, DWI, DCE-MRI
11 Completed Rectal Study: Value of Repeated FDG-PET-CT Scans in Rectal Cancer
Condition: Rectum Cancer
Intervention: Drug: FDG
12 Completed FDG-PET/CT in the Evaluation of Patients With Suspected Cholecystitis
Condition: Cholecystitis
Intervention: Drug: 18FDG (an FDA-approved radiopharmaceutical)
13 Recruiting FDG PET/CT in Monitoring Very Early Therapy Response in Patients With Glioblastoma
Condition: Glioblastoma
Interventions: Procedure: Computed Tomography;   Radiation: Fludeoxyglucose F-18;   Procedure: Positron Emission Tomography
14 Unknown  Clinical Trial to Evaluate the Safety and Clinical Utility of 18F-FDG Produced by the Molecular Imaging and Research Centre of Nova Scotia
Condition: 18FDG
Intervention:
15 Recruiting 18F-FDG PET/CT-based Prognostic Model for Predicting Outcome in Patients With Diffuse Large B-cell Lymphoma
Condition: Lymphoma, Large B-Cell, Diffuse
Intervention: Device: 18F-FDG PET/CT
16 Active, not recruiting 18-FDG PET/CT Imaging and Clinical Decisions in Infective Endocarditis
Condition: Infective Endocarditis
Intervention: Procedure: 18-FDG PET/CT scan
17 Recruiting The Benefit of FDG PET CT in the Treatment Algorithm of Staphylococcus Aureus Bacteremia
Condition: Staphylococcus Aureus Bacteremia
Intervention: Procedure: FDG PET CT
18 Recruiting uPAR PET/CT and FDG PET/MRI for Preoperative Staging of Bladder Cancer
Condition: Urinary Bladder Neoplasms
Interventions: Drug: Injection of 68Ga-NOTA-AE105;   Drug: Injection of 18F-FDG;   Device: Positron Emission Tomography and CT;   Device: Positron Emission Tomography and MRI
19 Terminated Predictive Value of FDG-PET-CT Scans for Patients With Lung Cancer Receiving Concurrent Chemo-Radiation
Conditions: Lung Cancer;   SCLC;   NSCLC
Intervention: Other: 18F-deoxyglucose (FDG)
20 Active, not recruiting FDG Tumor Heterogeneity During Chemoradiation as a Predictor of Response in Patients With Cervical Cancer
Conditions: Cervical Cancer;   Uterine Cervical Cancer;   Uterine Cervical Neoplasms
Interventions: Device: FDG-PET/MR;   Device: FDG-PET/CT

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.